Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study

[1]  R. Granell,et al.  The impact of asthma on mental health and wellbeing during COVID-19 lockdown , 2021, European Respiratory Journal.

[2]  C. Camargo,et al.  COVID-19 severity in asthma patients: a multi-center matched cohort study , 2021, The Journal of asthma : official journal of the Association for the Care of Asthma.

[3]  J. Soriano,et al.  The impact of COVID-19 on patients with asthma , 2020, European Respiratory Journal.

[4]  David A. Drew,et al.  Attributes and predictors of Long-COVID: analysis of COVID cases and their symptoms collected by the Covid Symptoms Study App , 2020, medRxiv.

[5]  Jordan J. Clark,et al.  Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study , 2020, American journal of respiratory and critical care medicine.

[6]  K. Bhaskaran,et al.  Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform , 2020, The Lancet Respiratory Medicine.

[7]  Anding Xu,et al.  Efficacy and Safety of Corticosteroid Treatment in Patients With COVID-19: A Systematic Review and Meta-Analysis , 2020, Frontiers in Pharmacology.

[8]  D. Spiegelhalter.  Use of “normal” risk to improve understanding of dangers of covid-19 , 2020, BMJ.

[9]  F. Hobbs,et al.  Asthma and COVID-19: review of evidence on risks and management considerations , 2020, BMJ Evidence-Based Medicine.

[10]  E. Wulff-Burchfield,et al.  Sex-bias in COVID-19-associated illness severity and mortality in cancer patients: A systematic review and meta-analysis , 2020, EClinicalMedicine.

[11]  K. Khunti,et al.  Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study , 2020, The Lancet Diabetes & Endocrinology.

[12]  T. Greenhalgh,et al.  Management of post-acute covid-19 in primary care , 2020, BMJ.

[13]  D. Sanchez-Ramirez,et al.  Underlying respiratory diseases, specifically COPD, and smoking are associated with severe COVID-19 outcomes: A systematic review and meta-analysis , 2020, Respiratory Medicine.

[14]  J. Hewitt,et al.  The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study , 2020, The Lancet Public Health.

[15]  N. Hopkinson,et al.  COVID-19 related concerns of people with long-term respiratory conditions: a qualitative study , 2020, BMC Pulmonary Medicine.

[16]  I. Pavord,et al.  Associations between COVID-19 infection, tobacco smoking and nicotine use, common respiratory conditions and inhaled corticosteroids: a prospective QResearch-Case Mix Programme data linkage study January-May 2020 , 2020, medRxiv.

[17]  J. Sterne,et al.  We should be cautious about associations of patient characteristics with COVID-19 outcomes that are identified in hospitalised patients , 2020 .

[18]  D. Halpin,et al.  Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective , 2020, European Respiratory Journal.

[19]  D. Halpin,et al.  Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? , 2020, The Lancet Respiratory Medicine.

[20]  David Shum,et al.  Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs , 2020, Antimicrobial Agents and Chemotherapy.

[21]  H. Momma,et al.  Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells , 2020, Respiratory Investigation.

[22]  Zhibo B. Xu,et al.  Inhaled corticosteroids and risk of upper respiratory tract infection in patients with asthma: a meta-analysis , 2018, Infection.

[23]  S. Erzurum,et al.  Asthma is Different in Women , 2015, Current Allergy and Asthma Reports.

[24]  B. Oliver,et al.  Viral infections and asthma: an inflammatory interface? , 2014, European Respiratory Journal.

[25]  D. Jarvis,et al.  Gender differences in prevalence, diagnosis and incidence of allergic and non-allergic asthma: a population-based cohort , 2012, Thorax.

[26]  S. Cole,et al.  Illustrating bias due to conditioning on a collider. , 2010, International journal of epidemiology.

[27]  R. Hubbard,et al.  Interstitial lung diseases: an epidemiological overview. , 2001, The European respiratory journal. Supplement.